- 1. 6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)
- [GRH/LHRH analog used to suppress circulating gonadotropin and sex steroid levels; USP lists as an antineoplastic. ( CSP )] (UMLS (NCI) C0085272) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine; Hormone =[AN000] ANTINEOPLASTICS;
D-His-6-Pro-8-NEt-LHRH;
peptide hormone analog;
[AN500] ANTINEOPLASTIC HORMONES =6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) Monoacetate | - 7. DL-Phenylalanine
- [A racemic mixture of phenylalanine, an aromatic amino acid with antidepressant, analgesic and appetite suppressant properties. The antidepressant effect of DL-phenylalanine may be accounted for by its precursor role in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain norepinephrine and dopamine levels are thought to be associated with antidepressant effects. This agent also plays a role in alleviating mood swings of premenstrual syndrome (PMS), increasing energy and mental alertness and heighten the ability to focus in individuals with attention deficit hyperactivity disorder (ADHD). ( NCI )] (UMLS (NCI) C0772277) PHENYLALANINE, DL-;
PHENYLALANINE,DL-;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 2. 6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) Monoacetate
- [The acetate salt of a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression. ( NCI )] (UMLS (NCI) C0700596) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig);
=LEUPROLIDE ACETATE 11.25 MG;
LEUPROLIDE ACETATE 15 MG;
LEUPROLIDE ACETATE 22.5 MG;
LEUPROLIDE ACETATE 30 MG;
LEUPROLIDE ACETATE 65 MG;
LEUPROLIDE ACETATE 72 MG;
LEUPROLIDE ACETATE 7.5 MG;
LEUPROLIDE ACETATE 1 MG/0.2ML;
LEUPROLIDE ACETATE 3.75 MG | - 8. DL717
- (UMLS (NCI) C0065187) =Organic Chemical; Pharmacologic Substance ;
|
- 3. D lactate dehydrogenase
- [ ] (UMLS (CSP) C0112125) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 9. DLEU1
- [Expressed in testis, thymus, small intestine, prostate, spleen, peripheral blood lymphocytes, and ovary and encoded by human DLEU1 Gene, DLEU1 Protein is a 72-amino acid putative tumor suppressor protein for BCLL. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1333222) DLEU1 Protein;
Leukemia Associated Protein 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 4. d,l-alpha-Tocopherol Acetate
- (UMLS (NCI) C0994472) dl-.alpha.-Tocopheryl acetate;
dl-alpha tocopheryl acetate;
dl-Alpha-Tocopheryl Acetate;
TOCOPHERYL ACETATE,DL-ALPHA;
TOCOPHERYL ACETATE,DL-ALPHA PREPARATION =Lipid; Pharmacologic Substance; Vitamin =(+/-)-alpha-Tocopherol;
=CARRINGTON FOOT CREAM;
ULTRACAL TUBE-FEEDING LIQUID;
dl-alpha tocopheryl acetate 200 MG/ML;
TOCOPHERYL ACETATE,DL-ALPHA 0 NS;
TOCOPHERYL ACETATE,DL-ALPHA 11 MG;
TOCOPHERYL ACETATE,DL-ALPHA 15 MG;
TOCOPHERYL ACETATE,DL-ALPHA 15 UNT;
TOCOPHERYL ACETATE,DL-ALPHA 2 UNT/ML;
TOCOPHERYL ACETATE,DL-ALPHA 30 MG;
TOCOPHERYL ACETATE,DL-ALPHA 30 UNT;
TOCOPHERYL ACETATE,DL-ALPHA 400 UNT;
TOCOPHERYL ACETATE,DL-ALPHA 5 MG;
TOCOPHERYL ACETATE,DL-ALPHA 5 UNT;
TOCOPHERYL ACETATE,DL-ALPHA 50 MG;
TOCOPHERYL ACETATE,DL-ALPHA 7.7 UNT;
| - 10. DLEU2
- [Expressed in thymus and testis and encoded by human DLEU2 Gene, DLEU2 Protein is an 84-amino acid 10-kD putative tumor suppressor protein. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1333224) DLEU2 Protein;
Leukemia Associated Protein 2 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 5. D52-Like 1
- [Expressed in kidney and skin by human TPD52L1 Gene (TPD52 Family), 204-aa 22-kDa Tumor Protein D52-Like 1 exhibits 52% identity to D52, a coiled-coil domain, and PEST domains. D52, D53, and D54 share significant homology, including a coiled-coil domain indicative of protein-protein interactions. TPD52L1 forms homodimers, or heterodimers with other family members. Like D52, TPD52L1 may be involved in calcium-mediated signal transduction and cell proliferation. ( NCI )] (UMLS (NCI) C1314855) D53;
hD53;
TPD52L1;
Tumor Protein D52-Like 1;
Tumor Protein D53;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 11. dlg protein
- [ ] (UMLS (CSP) C0165897) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 6. DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride
- [The hydrochloride salt form of mefloquine, a piperidinyl quinidine with antimalarial activity. Although the exact mechanism of mefloquine hydrochloride is largely unknown, this agent acts as a blood schizonticide and probably exert its actions by interacting with the phospholipid bilayer, thereby interfering with the stability of the cell membrane and causing cell lysis. Mefloquine hydrochloride is active against Plasmodium falciparum and Plasmodium vivax. ( NCI )] (UMLS (NCI) C0282398) =Organic Chemical; Pharmacologic Substance ;
=MEFLOQUINE;
=MEFLOQUINE HYDROCHLORIDE 250 MG;
| |
home
